MedTrace Logo

The Predictive Ability of 4MGS in IPF

NCT02436278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2017-11-09

No results posted yet for this study

Summary

This study investigates whether usual walking speed, measured by the 4 metre gait speed test (4MGS), and change in usual walking speed over 6 months predicts death and hospital admissions in patients with Idiopathic Pulmonary Fibrosis.

Conditions

Interventions

OTHER

4MGS

Usual walking speed measured over 4 metres

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • William DC Man, MC, PhD · Royal Brompton and Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-10-20
Completion
2017-10-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436278 on ClinicalTrials.gov